Aardvark Therapeutics, Inc. (AARD)
13.12
-0.10
(-0.76%)
USD |
NASDAQ |
Dec 31, 16:00
13.10
-0.02
(-0.15%)
After-Hours: 20:00
Aardvark Therapeutics Shareholders Equity (Quarterly): 122.38M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Insmed, Inc. | 945.57M |
| Immunic, Inc. | 10.50M |
| Soleno Therapeutics, Inc. | 494.80M |
| Rhythm Pharmaceuticals, Inc. | 148.82M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 133.23M |
| Total Liabilities (Quarterly) | 10.85M |
| Debt to Equity Ratio | 0.0045 |
| Current Ratio | 12.03 |
| Net Debt Paydown Yield | -0.04% |